S11 Ep38: FDA Approval Insights: Obe-Cel in B-Cell Precursor ALL

OncLive® On Air - Un pódcast de OncLive® On Air

Podcast artwork

Dr Shaughnessy discusses the significance of the FDA approval of obe-cel for patients with relapsed or refractory B-cell precursor ALL.

Visit the podcast's native language site